As expected, more compounds were annotated and validated using the additional spin system information provided by the TOCSY data from the C. elegans data than the G. biloba data in both solvents. This can be explained by the fact that the extracts of G. biloba is rich in secondary metabolites that outweigh the amount of primary metabolites. BMRB and HMDB contains mostly primary metabolites which can be readily identified in biofluids NMR data. No identification was achieved using the data collected from the G. biloba samples. Besides many compounds were annotated for the G. biloba HSQC data, the validation using the spin system provided by the TOCSY data failed to confirm any of the suggestions made.